Koopman; William J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Koopman; William J..The latest application filed is for "antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof".

Company Profile

0.12.12

Koopman; William J. - Indian Springs AL
Koopman, William J - Indian Springs AL
Koopman; William J. - Helena AL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof Grant 9,700,618 - Zhou , et al. July 11, 2	2017-07-11
Antibody Selective For A Tumor Necrosis Factor-related Apoptosis-inducing Ligand Receptor And Uses Thereof App 20140308288 - Zhou; Tong ; et al.	2014-10-16
Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor DR5 and uses thereof Grant 8,715,668 - Zhou , et al. May 6, 2	2014-05-06
Antibody Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Uses Thereof App 20130243780 - Zhou; Tong ; et al.	2013-09-19
Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof Grant 8,329,180 - Zhou , et al. December 11, 2	2012-12-11
Antibody Selective For A Tumor Necrosis Factor-related Apoptosis-inducing Ligand Receptor And Uses Thereof App 20120076792 - Zhou; Tong ; et al.	2012-03-29
Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof Grant 8,067,001 - Zhou , et al. November 29, 2	2011-11-29
Combinations of antibodies selective for DR5 and other therapeutic agents Grant 7,981,421 - Zhou , et al. July 19, 2	2011-07-19
Antibody Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Uses Thereof App 20110008324 - Zhou; Tong ; et al.	2011-01-13
Combinations Of Antibodies Selective For Dr5 And Other Therapeutic Agents App 20110002887 - Kimberly; Robert P. ; et al.	2011-01-06
Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof Grant 7,790,165 - Zhou , et al. September 7, 2	2010-09-07
Combinations of antibodies selective for DR5 and other therapeutic agents Grant 7,704,502 - Zhou , et al. April 27, 2	2010-04-27
Antibody Selective For Dr4 And Uses Thereof App 20090208483 - Zhou; Tong ; et al.	2009-08-20
Combinations of Antibodies Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Other Therapeutic Agents App 20090022707 - Kimberly; Robert P. ; et al.	2009-01-22
Antibody selective for DR4 and uses thereof Grant 7,476,383 - Zhou , et al. January 13, 2	2009-01-13
Antibody Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Uses Thereof App 20070298039 - Zhou; Tong ; et al.	2007-12-27
Combinations of DR5 antibodies and other therapeutic agents Grant 7,279,160 - Zhou , et al. October 9, 2	2007-10-09
Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof Grant 7,244,429 - Zhou , et al. July 17, 2	2007-07-17
Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof App 20030198637 - Zhou, Tong ; et al.	2003-10-23
Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof App 20030190687 - Zhou, Tong ; et al.	2003-10-09
Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents App 20030133932 - Zhou, Tong ; et al.	2003-07-17
10-deazaaminopterin: a new arthritis remittive drug Grant 5,030,634 - Krumdieck , et al. July 9, 1	1991-07-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.